EnglishEspañolFrançais
EnglishEspañolFrançais
PRODUCTS > Biomarker > COVID-19 IgM Antibody Detection Kit (CLIA)

COVID-19 IgM Antibody Detection Kit (CLIA)

This kit is used for in vitro qualitative detection of novel coronavirus (SARS-CoV-2) IgM antibodies in human serum samples. It is used in conjunction with nucleic acid detection and cannot be used as a basis for the diagnosis and elimination of novel coronavirus pneumonia. It cannot be used for general population screening.

Share

Name

COVID-19 IgM Antibody Detection Kit (CLIA)

Method

Chemiluminescence Immunoassay

Sample type

Serum

Specification

12 tests/kit

Instrument

Full-Automatic Chemiluminescence Immunoassay System (FACIS-I)

Detection time

40 min

Detection objects

COVID-19

Stability

The kit is stable for 1 year at 2-8°C